Ksenija Pavletic is a Partner and Chief Commercial Officer (“CCO”) at Jeito Capital with over 25 years’ experience in pharma & biotech.

She is an expert in both investment strategies and healthcare companies scaleups with a successful track record in fundraising, M&A, company and team build-ups, commercial organization build-ups, product launches, and market access.

As part of the Jeito founding team, Ksenija contributed to Jeito’s development as Chief Commercial Officer before being promoted to Partner Investor in November 2023. Prior to joining Jeito, she was CEO of Swiss-based, reproductive health pharma company PregLem SA where she led the company’s rapid expansion including its successful exit for CHF445 million three years after its inception. Prior to PregLem, Ksenija worked for eleven years with Serono (then Merck Serono) in various regional and global business, sales, and marketing positions.

Ksenija holds a M.Sc. in Biotechnology from the University of Zagreb and an MBA from the American Graduate School of Business. She is also a member of W.I.T.H. (Women Innovating Together in Healthcare).